Cargando…

Hypercapnic BOLD MRI compared to H(2)(15)O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease

BACKGROUND AND PURPOSE: Patients with Moyamoya Disease (MMD) need hemodynamic evaluation of vascular territories at risk of stroke. Today's investigative standards include H(2)(15)O PET/CT with pharmacological challenges with acetazolamide (ACZ). Recent developments suggest that CO(2)-triggered...

Descripción completa

Detalles Bibliográficos
Autores principales: Hauser, Till-Karsten, Seeger, Achim, Bender, Benjamin, Klose, Uwe, Thurow, Johannes, Ernemann, Ulrike, Tatagiba, Marcos, Meyer, Philipp T., Khan, Nadia, Roder, Constantin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370561/
https://www.ncbi.nlm.nih.gov/pubmed/30743136
http://dx.doi.org/10.1016/j.nicl.2019.101713
_version_ 1783394366008590336
author Hauser, Till-Karsten
Seeger, Achim
Bender, Benjamin
Klose, Uwe
Thurow, Johannes
Ernemann, Ulrike
Tatagiba, Marcos
Meyer, Philipp T.
Khan, Nadia
Roder, Constantin
author_facet Hauser, Till-Karsten
Seeger, Achim
Bender, Benjamin
Klose, Uwe
Thurow, Johannes
Ernemann, Ulrike
Tatagiba, Marcos
Meyer, Philipp T.
Khan, Nadia
Roder, Constantin
author_sort Hauser, Till-Karsten
collection PubMed
description BACKGROUND AND PURPOSE: Patients with Moyamoya Disease (MMD) need hemodynamic evaluation of vascular territories at risk of stroke. Today's investigative standards include H(2)(15)O PET/CT with pharmacological challenges with acetazolamide (ACZ). Recent developments suggest that CO(2)-triggered blood‑oxygen-level-dependent (BOLD) functional MRI might provide comparable results to current standard methods for evaluation of territorial hemodynamics, while being a more widely available and easily implementable method. This study examines results of a newly developed quantifiable analysis algorithm for CO(2)-triggered BOLD MRI in Moyamoya patients and correlates the results with H(2)(15)O PET/CT with ACZ challenge to assess comparability between both modalities. METHODS: CO(2)-triggered BOLD MRI was performed and compared to H(2)(15)O PET/CT with ACZ challenge in patients with angiographically proven MMD. Images of both modalities were analyzed retrospectively in a blinded, standardized fashion by visual inspection, as well as with a semi-quantitative analysis using stimuli-induced approximated regional perfusion-weighted data and BOLD-signal changes with reference to cerebellum. RESULTS: 20 consecutive patients fulfilled the inclusion criteria, a total of 160 vascular territories were analyzed retrospectively. Visual analysis (4-step visual rating system) of standardized, color-coded cerebrovascular reserve/reactivity maps showed a very strong correlation (Spearman's rho = 0.9, P < 0.001) between both modalities. Likewise, comparison of approximated regional perfusion changes across vascular territories (normalized to cerebellar change) reveal a highly significant correlation between both methods (Pearson's r = 0.71, P < 0.001). CONCLUSIONS: The present analysis indicates that CO(2)-triggered BOLD MRI is a very promising tool for the hemodynamic evaluation of MMD patients with results comparable to those seen in H(2)(15)O PET/CT with ACZ challenge. It therefore holds future potential in becoming a routine examination in the pre- and postoperative evaluation of MMD patients after further prospective evaluation.
format Online
Article
Text
id pubmed-6370561
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-63705612019-02-21 Hypercapnic BOLD MRI compared to H(2)(15)O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease Hauser, Till-Karsten Seeger, Achim Bender, Benjamin Klose, Uwe Thurow, Johannes Ernemann, Ulrike Tatagiba, Marcos Meyer, Philipp T. Khan, Nadia Roder, Constantin Neuroimage Clin Regular Article BACKGROUND AND PURPOSE: Patients with Moyamoya Disease (MMD) need hemodynamic evaluation of vascular territories at risk of stroke. Today's investigative standards include H(2)(15)O PET/CT with pharmacological challenges with acetazolamide (ACZ). Recent developments suggest that CO(2)-triggered blood‑oxygen-level-dependent (BOLD) functional MRI might provide comparable results to current standard methods for evaluation of territorial hemodynamics, while being a more widely available and easily implementable method. This study examines results of a newly developed quantifiable analysis algorithm for CO(2)-triggered BOLD MRI in Moyamoya patients and correlates the results with H(2)(15)O PET/CT with ACZ challenge to assess comparability between both modalities. METHODS: CO(2)-triggered BOLD MRI was performed and compared to H(2)(15)O PET/CT with ACZ challenge in patients with angiographically proven MMD. Images of both modalities were analyzed retrospectively in a blinded, standardized fashion by visual inspection, as well as with a semi-quantitative analysis using stimuli-induced approximated regional perfusion-weighted data and BOLD-signal changes with reference to cerebellum. RESULTS: 20 consecutive patients fulfilled the inclusion criteria, a total of 160 vascular territories were analyzed retrospectively. Visual analysis (4-step visual rating system) of standardized, color-coded cerebrovascular reserve/reactivity maps showed a very strong correlation (Spearman's rho = 0.9, P < 0.001) between both modalities. Likewise, comparison of approximated regional perfusion changes across vascular territories (normalized to cerebellar change) reveal a highly significant correlation between both methods (Pearson's r = 0.71, P < 0.001). CONCLUSIONS: The present analysis indicates that CO(2)-triggered BOLD MRI is a very promising tool for the hemodynamic evaluation of MMD patients with results comparable to those seen in H(2)(15)O PET/CT with ACZ challenge. It therefore holds future potential in becoming a routine examination in the pre- and postoperative evaluation of MMD patients after further prospective evaluation. Elsevier 2019-02-04 /pmc/articles/PMC6370561/ /pubmed/30743136 http://dx.doi.org/10.1016/j.nicl.2019.101713 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Hauser, Till-Karsten
Seeger, Achim
Bender, Benjamin
Klose, Uwe
Thurow, Johannes
Ernemann, Ulrike
Tatagiba, Marcos
Meyer, Philipp T.
Khan, Nadia
Roder, Constantin
Hypercapnic BOLD MRI compared to H(2)(15)O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease
title Hypercapnic BOLD MRI compared to H(2)(15)O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease
title_full Hypercapnic BOLD MRI compared to H(2)(15)O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease
title_fullStr Hypercapnic BOLD MRI compared to H(2)(15)O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease
title_full_unstemmed Hypercapnic BOLD MRI compared to H(2)(15)O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease
title_short Hypercapnic BOLD MRI compared to H(2)(15)O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease
title_sort hypercapnic bold mri compared to h(2)(15)o pet/ct for the hemodynamic evaluation of patients with moyamoya disease
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370561/
https://www.ncbi.nlm.nih.gov/pubmed/30743136
http://dx.doi.org/10.1016/j.nicl.2019.101713
work_keys_str_mv AT hausertillkarsten hypercapnicboldmricomparedtoh215opetctforthehemodynamicevaluationofpatientswithmoyamoyadisease
AT seegerachim hypercapnicboldmricomparedtoh215opetctforthehemodynamicevaluationofpatientswithmoyamoyadisease
AT benderbenjamin hypercapnicboldmricomparedtoh215opetctforthehemodynamicevaluationofpatientswithmoyamoyadisease
AT kloseuwe hypercapnicboldmricomparedtoh215opetctforthehemodynamicevaluationofpatientswithmoyamoyadisease
AT thurowjohannes hypercapnicboldmricomparedtoh215opetctforthehemodynamicevaluationofpatientswithmoyamoyadisease
AT ernemannulrike hypercapnicboldmricomparedtoh215opetctforthehemodynamicevaluationofpatientswithmoyamoyadisease
AT tatagibamarcos hypercapnicboldmricomparedtoh215opetctforthehemodynamicevaluationofpatientswithmoyamoyadisease
AT meyerphilippt hypercapnicboldmricomparedtoh215opetctforthehemodynamicevaluationofpatientswithmoyamoyadisease
AT khannadia hypercapnicboldmricomparedtoh215opetctforthehemodynamicevaluationofpatientswithmoyamoyadisease
AT roderconstantin hypercapnicboldmricomparedtoh215opetctforthehemodynamicevaluationofpatientswithmoyamoyadisease